HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan I Silverberg Selected Research

carbamix

11/2022Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018.
1/2022Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005-2018.
5/2021Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan I Silverberg Research Topics

Disease

137Atopic Dermatitis (Atopic Eczema)
12/2024 - 02/2015
53Eczema
05/2024 - 09/2014
41Contact Dermatitis (Eczema, Contact)
04/2024 - 05/2015
28Pruritus (Itching)
11/2023 - 12/2016
24Hypersensitivity (Allergy)
12/2023 - 01/2010
24Allergic Contact Dermatitis
12/2023 - 06/2018
22Dermatitis
02/2024 - 03/2015
17Infections
03/2023 - 01/2009
16Inflammation (Inflammations)
12/2023 - 01/2010
14Psoriasis (Pustulosis Palmaris et Plantaris)
02/2024 - 07/2016
12Asthma (Bronchial Asthma)
03/2024 - 02/2012
11Pain (Aches)
03/2024 - 12/2018
11COVID-19
08/2023 - 01/2021
9Skin Diseases (Skin Disease)
02/2024 - 04/2021
7Vitiligo
03/2024 - 06/2010
7Conjunctivitis
12/2023 - 12/2016
5Food Hypersensitivity (Food Allergy)
02/2023 - 02/2012
5Seasonal Allergic Rhinitis (Hay Fever)
11/2022 - 02/2015
4Autoimmune Diseases (Autoimmune Disease)
08/2023 - 06/2010
4Respiratory Tract Infections (Respiratory Tract Infection)
12/2022 - 06/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 03/2021
4Neoplasms (Cancer)
10/2022 - 11/2016
3Erythema
05/2024 - 11/2020
3Necrosis
04/2023 - 10/2011
3Injection Site Reaction
01/2023 - 12/2016
3Opportunistic Infections (Opportunistic Infection)
12/2022 - 07/2019
3Chronic Disease (Chronic Diseases)
12/2021 - 04/2015
3Pemphigus (Pemphigus Vulgaris)
12/2021 - 12/2017
3Dermatomyositis (Dermatopolymyositis)
12/2021 - 01/2017
3Obesity
04/2021 - 03/2015
3Acne Vulgaris
01/2021 - 06/2020
3Osteoporosis
05/2020 - 12/2017
3Herpes Zoster
06/2019 - 01/2009
3Hypertension (High Blood Pressure)
01/2018 - 03/2015
3Chickenpox
02/2012 - 01/2009
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023 - 01/2020
2Rheumatoid Arthritis
09/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

32AllergensIBA
04/2024 - 01/2010
28Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024 - 04/2015
28dupilumabIBA
01/2024 - 12/2016
24Immunoglobulin A (IgA)IBA
05/2024 - 06/2009
18abrocitinibIBA
12/2023 - 01/2020
11Janus Kinase InhibitorsIBA
03/2024 - 06/2019
11CytokinesIBA
12/2023 - 01/2009
11baricitinibIBA
10/2023 - 04/2019
11Immunoglobulin E (IgE)IBA
05/2023 - 01/2009
11Irritants (Vesicants)IBA
11/2022 - 09/2019
10upadacitinibIBA
05/2024 - 01/2020
9Interleukin-13IBA
12/2023 - 12/2016
9tralokinumabIBA
12/2023 - 01/2019
9Janus Kinase 1IBA
10/2023 - 01/2020
8Monoclonal AntibodiesIBA
12/2023 - 12/2016
8Immunoglobulin G (IgG)IBA
02/2023 - 01/2009
8AntibodiesIBA
02/2023 - 01/2009
7Janus KinasesIBA
03/2024 - 01/2021
7Ointments (Pastes)IBA
02/2024 - 05/2011
7AutoantibodiesIBA
08/2023 - 09/2012
6Phosphodiesterase 4 InhibitorsIBA
02/2024 - 04/2018
6Biomarkers (Surrogate Marker)IBA
05/2023 - 02/2011
6CosmeticsIBA
03/2023 - 12/2018
5lebrikizumabIBA
05/2024 - 01/2023
5ruxolitinibIBA
05/2024 - 01/2023
5crisaboroleIBA
02/2024 - 04/2018
5InterleukinsIBA
12/2023 - 07/2017
5Petrolatum (Vaseline)FDA Link
11/2023 - 03/2021
5Immunosuppressive Agents (Immunosuppressants)IBA
07/2023 - 01/2016
4Proteins (Proteins, Gene)FDA Link
12/2023 - 03/2021
4NickelIBA
12/2023 - 03/2015
44-phenylenediamine (p-phenylenediamine)FDA Link
11/2023 - 01/2021
42-methyl-4-isothiazolin-3-oneIBA
10/2023 - 04/2021
4Oxygen (Dioxygen)IBA
02/2023 - 01/2021
4Interleukin-4 (Interleukin 4)IBA
01/2021 - 01/2009
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2024 - 12/2023
3Calcineurin InhibitorsIBA
03/2024 - 11/2016
3TabletsIBA
04/2023 - 07/2012
3EmollientsIBA
02/2023 - 06/2018
3Peruvian balsam (balsam of Peru)IBA
11/2022 - 04/2021
3carbamixIBA
11/2022 - 05/2021
34-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
10/2021 - 12/2018
3CholesterolIBA
04/2021 - 03/2015
3ORALIT (ORS)IBA
03/2021 - 05/2015
3VaccinesIBA
01/2021 - 12/2009
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 07/2019
3Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2020 - 12/2016
2TYK2 Kinase (Tyrosine Kinase 2)IBA
03/2024 - 01/2021
2tapinarofIBA
02/2024 - 12/2023
2CobaltIBA
12/2023 - 11/2022
2nickel sulfateFDA Link
12/2023 - 04/2021
2Potassium DichromateFDA Link
12/2023 - 01/2022
2Coloring Agents (Dyes)IBA
11/2023 - 03/2021
2Hair DyesIBA
11/2023 - 01/2021
2nemolizumabIBA
10/2023 - 01/2020
2ClaudinsIBA
08/2023 - 01/2019
2Amyloid (Amyloid Fibrils)IBA
08/2023 - 02/2023
2Peptides (Polypeptides)IBA
08/2023 - 02/2023

Therapy/Procedure

49Therapeutics
03/2024 - 05/2011
7Length of Stay
12/2022 - 07/2016
6Phototherapy (Light Therapy)
12/2023 - 09/2016
3Baths
01/2022 - 11/2017
2Retreatment
12/2023 - 01/2022